Furthermore, Fig. 6F shows that GP73-SP treatment increased the migration and invasiveness of HepG2 and PLC cells but RVGG-SP or ΔTMD-SP had no effect on HCC cells. The gene discussed is GOLM1; the disease is hepatocellular carcinoma.